Background Despite the high rate of sudden death after myocardial infarction among
patients with a low ejection fraction, implantable cardioverter–defibrillators are …

Objectives: The aim of this study was to describe usage of the wearable cardioverter-
defibrillator (WCD) during mandated waiting periods following myocardial infarction (MI) for …

Sudden cardiac death (SCD) accounts for> 300 000 deaths in the United States annually. 1
Although the majority of these deaths occur in low-risk populations2 in which aggressive …

Background—Prospective data on the safety and efficacy of the wearable cardioverter
defibrillator (WCD) in a real-world setting are lacking. The Prospective Registry of Patients …

The wearable cardioverter-defibrillator has been available for over a decade and now is
frequently prescribed for patients deemed at high arrhythmic risk in whom the underlying …

Background: This study evaluated the wearable cardioverter-defibrillator (WCD) for use and
effectiveness in preventing sudden death caused by ventricular tachyarrhythmia or …

Objectives: This study sought to synthesize the available evidence on the use of the
wearable cardioverter-defibrillator (WCD). Background: Observational WCD studies for the …

The implantable cardioverter defibrillator (ICD) is able to reduce sudden arrhythmic death in
patients who are considered to be at high risk. However, the arrhythmic risk may be …

The automatic ICD improves survival in patients with a history of sudden cardiac arrest.
However, some patients do not meet the guidelines for ICD implantation or are unable to …

Objectives: The purpose of this study was to determine patient compliance and effectiveness
of antiarrhythmic treatment by the wearable cardioverter-defibrillator (WCD). Background …